NCT03059485 2026-02-04DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced RemissionBeth Israel Deaconess Medical CenterPhase 2 Active not recruiting82 enrolled
NCT05179824 2025-05-06Tempus Priority Study: A Pan-tumor Observational StudyTempus AIActive not recruiting1,000 enrolled
NCT00085709 2015-09-30S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLSWOG Cancer Research NetworkPhase 3 Completed637 enrolled 7 charts
NCT00411281 2015-09-30Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative DisorderChildren's Oncology GroupPhase 3 Withdrawn